Envestnet Portfolio Solutions, Inc.

Position in GILD — Gilead Sciences, Inc.

CIK 1998033 BERWYN, PA

Position in GILD

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$10,967,828

-$1,360,145 QoQ

Shares Held

86,812

-1.9% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.30%

of 13F equity value

Holder Rank

#416

of 2,266 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Envestnet Portfolio Solutions, Inc. holds $145,353,758 across 14 Drug Manufacturers - General names. GILD ranks #5 (7.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	41,689	$50,003,041
2	ABBV	AbbVie Inc.	89,324	$22,477,491
3	JNJ	Johnson & Johnson	71,666	$18,201,014
4	MRK	Merck & Co., Inc.	105,500	$13,556,750
5	GILD	Gilead Sciences, Inc. This page	86,812	$10,967,828
6	AMGN	Amgen Inc	24,293	$8,796,981
7	BMY	Bristol Myers Squibb Co	108,514	$6,252,576
8	PFE	Pfizer Inc	179,745	$4,328,259

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$10,967,828	86,812	-1.9%	Shares	Sole	2026-07-20
2026-03-31	$12,327,973	88,455	-16.2%	Shares	Sole	2026-04-29
2025-12-31	$12,962,325	105,608	+5.5%	Shares	Sole	2026-02-06
2025-09-30	$11,111,988	100,108	+90.1%	Shares	Sole	2025-10-30
2025-06-30	$5,837,416	52,651	-24.6%	Shares	Sole	2025-07-25
2025-03-31	$7,820,865	69,798	-37.6%	Shares	Sole	2025-04-21
2024-12-31	$10,324,379	111,772	+6.5%	Shares	Sole	2025-02-10
2024-09-30	$8,799,594	104,957	-1.2%	Shares	Sole	2024-10-31
2024-06-30	$7,287,136	106,211	-5.8%	Shares	Sole	2024-07-16
2024-03-31	$8,258,424	112,743	+31.8%	Shares	Sole	2024-05-06
2023-12-31	$6,928,947	85,532	-1.8%	Shares	Sole	2024-02-07
2023-09-30	$6,524,051	87,057	—	Shares	Sole	2023-11-13
No filing history on record for this holder in this stock.